Asia-Pacific (APAC) Biotechnology Market Summary, Competitive Analysis and Forecast to 2028
Summary
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
- The Asia-Pacific biotechnology market recorded revenues of $364.5 billion in 2023, representing a compound annual growth rate (CAGR) of 10.5% between 2018 and 2023.
- The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $220.2 billion, equivalent to 60.4% of the market's overall value.
- The Asia-Pacific biotechnology market is experiencing growth due to innovation and potential therapeutic developments. Government initiatives are driving growth in the industry, such as Japan's $3 billion investment in the Drug Development Venture Ecosystem Enhancement Project and China's emphasis on research and development.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts
- What was the size of the Asia-Pacific biotechnology market by value in 2023?
- What will be the size of the Asia-Pacific biotechnology market in 2028?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Asia-Pacific's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do the leading players follow?
- 7.3. What is the rationale behind recent M&A activity?
- 8 Company Profiles
- 8.1. Takeda Pharmaceutical Company Limited
- 8.2. Shanghai Kehua Bio-engineering Co Ltd
- 8.3. Astellas Pharma Inc.
- 8.4. Daiichi Sankyo Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Asia-Pacific biotechnology industry value: $ million, 2018-23
- Table 2: Asia-Pacific biotechnology industry category segmentation: % share, by value, 2018-2023
- Table 3: Asia-Pacific biotechnology industry category segmentation: $ million, 2018-2023
- Table 4: Asia-Pacific biotechnology industry geography segmentation: $ million, 2023
- Table 5: Asia-Pacific biotechnology industry value forecast: $ million, 2023-28
- Table 6: Takeda Pharmaceutical Company Limited: key facts
- Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
- Table 8: Takeda Pharmaceutical Company Limited: Key Employees
- Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
- Table 10: Shanghai Kehua Bio-engineering Co Ltd: key facts
- Table 11: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
- Table 12: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
- Table 13: Astellas Pharma Inc.: key facts
- Table 14: Astellas Pharma Inc.: Annual Financial Ratios
- Table 15: Astellas Pharma Inc.: Key Employees
- Table 16: Daiichi Sankyo Co Ltd: key facts
- Table 17: Daiichi Sankyo Co Ltd: Annual Financial Ratios
- Table 18: Daiichi Sankyo Co Ltd: Key Employees
- Table 19: Daiichi Sankyo Co Ltd: Key Employees Continued
- Table 20: Asia-Pacific exchange rate, 2019-23
- List of Figures
- Figure 1: Asia-Pacific biotechnology industry value: $ million, 2018-23
- Figure 2: Asia-Pacific biotechnology industry category segmentation: $ million, 2018-2023
- Figure 3: Asia-Pacific biotechnology industry geography segmentation: % share, by value, 2023
- Figure 4: Asia-Pacific biotechnology industry value forecast: $ million, 2023-28
- Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2023
- Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2023
- Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2023
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2023
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2023
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook